Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
Archivo
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Contenido de curso
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Objetivos de formación
Please see our websie for all the details www.cancerlearning.com
Destinatario
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants
Observaciones
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/548
 

Información e inscripción:

Mr. Duane Fowler
 
Categorías
Oncología
Idioma
Inglés
Costos
no registration fee
Cantacto organizador
3500 Maple Ave. Ste. 700
75219 Dallas
USA
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Ärztekammer für WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTreeHelix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.European Health Forum GasteinAlumni Club Medizinische Universität Wien